AstraZeneca Boosts Earnings Forecast on Strong Cancer Drug Sales
Anglo-Swedish pharmaceutical company, AstraZeneca, has revised its earnings forecast for the year following a surge in sales of cancer medicines. Despite a decline in sales of COVID vaccines, the company…